Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Cristina Benito‐Villalvilla"'
1
Akademický článek
Grass pollen allergoids conjugated with mannan for subcutaneous and sublingual immunotherapy: a dose-finding study
Autor: Pedro Ojeda, María Concepción Barjau, Javier Subiza, Antonio Moreno, Isabel Ojeda, Emilio Solano, Alicia Alonso, Raquel Caballero, Sandra Del Pozo, Marta Gómez-Perosanz, José Luis Sánchez-Trincado, Cristina Benito-Villalvilla, Alba Angelina, Irene Soria, Pedro A. Reche, Oscar Palomares, José Luis Subiza, Miguel Casanovas
Publikováno v: Frontiers in Immunology, Vol 15 (2024)
BackgroundPolymerized allergoids conjugated with mannan represent a novel approach of allergen immunotherapy targeting dendritic cells. In this study, we aimed to determine the optimal dose of mannan-allergoid conjugates derived from grass pollen (Ph
Externí odkaz: https://doaj.org/article/68dbca2d079b4619a7822b69b8d02335
Zobrazit plný text záznamu
2
Akademický článek
A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections
Autor: Leticia Martin-Cruz, Carmen Sevilla-Ortega, Cristina Benito-Villalvilla, Carmen M. Diez‐Rivero, Silvia Sanchez-Ramón, José Luis Subiza, Oscar Palomares
Publikováno v: Frontiers in Immunology, Vol 11 (2021)
Recurrent urinary tract infections (RUTIs) and recurrent vulvovaginal candidiasis (RVVCs) represent major healthcare problems with high socio-economic impact worldwide. Antibiotic and antifungal prophylaxis remain the gold standard treatments for RUT
Externí odkaz: https://doaj.org/article/9fd9997e12d54d60bf48809350fa1f02
Zobrazit plný text záznamu
4
Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring
Autor: Mario Pérez-Diego, Oscar Palomares, Kai Kisand, Alba Angelina, Ana Rebane, José Luis Subiza, Cristina Benito-Villalvilla
Publikováno v: E-Prints Complutense. Archivo Institucional de la UCM
instname
Background Allergoid–mannan conjugates are novel vaccines for allergen-specific immunotherapy being currently assayed in phase 2 clinical trials. Allergoid–mannan conjugates target dendritic cells (DCs) and generate functional forkhead box P3 (FO
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b374b9b2e568f7e148656a6d093f8e28
https://eprints.ucm.es/id/eprint/70115/
Zobrazit plný text záznamu
5
Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs
Autor: Irene Soria, Mario Pérez-Diego, José Luis Subiza, Oscar Palomares, Cristina Benito-Villalvilla, Enrique Fernández-Caldas
Publikováno v: Allergy
Background Polymerized allergoids conjugated to mannan (PM) are suitable vaccines for allergen‐specific immunotherapy (AIT). Alum remains the most widely used adjuvant in AIT, but its way of action is not completely elucidated. The better understan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e2282cde389dc54fb1969e897cc8d6
http://europepmc.org/articles/PMC7079174
Zobrazit plný text záznamu
7
A Combination of Polybacterial MV140 and
Autor: Leticia, Martin-Cruz, Carmen, Sevilla-Ortega, Cristina, Benito-Villalvilla, Carmen M, Diez-Rivero, Silvia, Sanchez-Ramón, José Luis, Subiza, Oscar, Palomares
Publikováno v: Frontiers in Immunology
Recurrent urinary tract infections (RUTIs) and recurrent vulvovaginal candidiasis (RVVCs) represent major healthcare problems with high socio-economic impact worldwide. Antibiotic and antifungal prophylaxis remain the gold standard treatments for RUT
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b108888ecb3f73284f5661b46441a03f
https://pubmed.ncbi.nlm.nih.gov/33552074
Zobrazit plný text záznamu
9
Novel vaccines targeting dendritic cells by coupling allergoids to mannan
Autor: José Luis Subiza, Irene Soria, Oscar Palomares, Cristina Benito-Villalvilla
Publikováno v: Allergo Journal International
Allergen-specific immunotherapy (AIT) is the single disease-modifying treatment for allergy. Clinical trials show AIT to be safe and effective for many patients; however, it still faces problems related to efficacy, safety, long treatment duration an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e45adbc2a75ef19179887b7998dfbcd
http://europepmc.org/articles/PMC6267119
Zobrazit plný text záznamu
10
Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways
Autor: Silvia Sánchez-Ramón, Laura Conejero, Sofía Sirvent, Beatriz Perez-Villamil, José Luis Subiza, Juliana Lucía Ochoa, Lourdes Hernández-Cillero, Oscar Palomares, Cristina Cirauqui, Paola Brandi, David Sancho, Carmen M. Diez-Rivero, Cristina Benito-Villalvilla
Publikováno v: European Journal of Immunology
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Recurrent respiratory tract infections (RRTIs) are the first leading cause of community-and nosocomial-acquired infections. Antibiotics remain the mainstay of treatment, enhancing the potential to develop antibiotic resistances. Therefore, the develo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5abce0300e777fb27c985ee27ad1683e
https://doi.org/10.1002/eji.201747024
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje